Kadono, Toru
Yamamoto, Shun
Hirose, Toshiharu
Ikeda, Go
Ohara, Akihiro
Itoyama, Mai
Yokoyama, Kazuki
Honma, Yoshitaka
Hashimoto, Taiki
Sekine, Shigeki
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Kato, Ken http://orcid.org/0000-0002-1733-5072
Article History
Received: 16 June 2022
Accepted: 21 August 2022
First Online: 1 September 2022
Declarations
:
: SY has received honoraria for lectures from Ono Pharmaceutical and Bristol-Myers Squibb. YH has received research grants and honoraria for lectures from Ono Pharmaceutical and Bristol Myers Squibb. SS has received research grants from AstraZeneca and honoraria for lectures from Roche and MSD. KK has received research grants and honoraria for lectures from Ono Pharmaceutical and Bristol-Myers Squibb. The other authors declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.